Inventor profile of:

Frank TEGTMEIER

City:

Bielefeld

Country:

Germany

Published Applications:

11

Last publication date:

2026-02-19

Top Assignees for applications by Frank TEGTMEIER

The entities that hold a legal rights for patent applications filed by inventor TEGTMEIER Frank:

Recent patent applications by TEGTMEIER Frank

Frank TEGTMEIER from Bielefeld, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-19
US20260048056A1
Human necessities

SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS

#2 | 2023-11-09
US20230355630A1
Human necessities

SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS

#3 | 2022-02-03
US20220031703A9
Human necessities

Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

#4 | 2021-05-13
US20210137927A1
Human necessities

SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS

#5 | 2020-02-13
US20200046710A1
Human necessities

Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

#6 | 2018-10-11
US20180289714A1
Human necessities

Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

#7 | 2017-10-19
US20170296543A1
Human necessities

Solid pharmaceutical compositions comprising biopterin derivatives and uses of suchcompositions

#8 | 2017-04-27
US20170112836A1
Human necessities

Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

#9 | 2013-07-18
US20130184281A1
Chemistry; metallurgy

Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species

#10 | 2013-05-23
US20130131071A1
Human necessities

Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species

#11 | 2007-02-08
US20070032498A1
Chemistry; metallurgy

Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species

InventorID:

263789 ⎘